Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Prostatic Neoplasms 10Lung Neoplasms 10Breast Neoplasms 8Pancreatic Neoplasms 5Multiple Myeloma 5Brain Neoplasms 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Papillomavirus Infections 4Ovarian Neoplasms 4Leukemia, Myeloid, Acute 4Hematopoietic and Lymphatic System Neoplasm 4Carcinoma, Non-Small-Cell Lung 4Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Melanoma 2Inflammatory Breast Neoplasms 2Glioblastoma 2Fallopian Tube Neoplasms 2Soft Tissue Neoplasms 1Skin Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Resectable Lung Non-Small Cell Carcinoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Patient Compliance 1Pancreatic Ductal Adenocarcinoma 1Obesity 1

Interventions

Curcumin 2Specimen Handling 1Probiotics 1Oxycodone 1Music Therapy 1Moxifloxacin 1Morphine 1Methadone 1Glucose 1Docosahexaenoic Acids 1Diet, Plant-Based 1Diet, Mediterranean 1Ciprofloxacin 1Amoxicillin-Potassium Clavulanate Combination 14-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Monoclonal Gammopathy of Undetermined Significance × Specimen Handling × Clear all
NCT03119883 2024-08-09

Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma

Mayo Clinic

Phase NA Completed
35 enrolled
Plasma cell

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡